Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

PCOS is common in women, often treated with lifestyle changes and oral contraceptives.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

The study found no significant link between Helicobacter pylori infection and polycystic ovary syndrome in young females.

Women with PCOS, especially with hirsutism, should be screened for depression and anxiety.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.